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Abstract 
Background: In 2014, Joint Commission recommended palliative care (PC) engagement in 
ventricular assist device (VAD) implantation as destination therapy. Limited information is 
available on established PC protocols in the mechanical circulatory support (MCS) population.  
Measures: The goals of our PC consultation were to document advance care planning (ACP) 
discussions and designate a surrogate decision maker (SDM) prior to MCS implantation. A 
retrospective analysis compared the frequency of PC consults, ACP discussion, and SDM before 
and after protocol implementation.   
Intervention: A protocol was developed to conduct interdisciplinary PC consultations for the 
MCS population.   
Outcomes: The percentage of PC consults placed prior to MCS implantation increased from 11 
(17.2%) pre-protocol to 56 (96.6%) post-protocol (p<0.0001), and documented SDM increased 
from 26 (40.6%) pre-protocol to 57 (98.3%) post protocol (p<0.0001).     
Conclusion: Close PC/cardiology collaboration can substantially improve ACP discussions and 
SDM documentation in the MCS population. This multidisciplinary protocol facilitates 
successful PC consultations.  
Key words: Palliative Care, Mechanical Circulatory Support, Advance Care Planning, Surrogate 
Decision Maker, Ventricular Assist Device   
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BACKGROUND 
  Approximately 5.7 million Americans are currently diagnosed with heart failure with 
about 300,000 deaths per year. The prevalence has doubled over the last 25 years and is 
estimated to double again between 2030 and 2040 with the aging of the population.1 When 
patients fail to respond to medical therapies, they are considered for advanced therapies such as 
heart transplant and mechanical circulatory support (MCS) devices. The two-year survival for 
continuous flow ventricular assist devices (VAD) in patients with low risk of complications has 
been shown to parallel that of cardiac transplantation, with patients reporting improved quality of 
life and functional capacity.2 However, the majority of patients are at an increased risk of 
complications such as bleeding, infection, stroke, pump thrombosis, and respiratory failure 
amongst others.3 These can add significant stress and symptom burden to patients and their 
families. Additionally, the patients getting these devices as destination therapy (DT) will face the 
end of life with the VAD in place. Due to the need for advance care planning (ACP) and 
symptom management, the Centers for Medicare and Medicaid Services and The Joint 
Commission recommended in 2014 that a PC representative experienced with the VAD 
population be part of the interdisciplinary team based on patient and family needs.4  
  Swetz et al. proposed that a preparedness plan /ACP should be incorporated as part of a 
PC evaluation in this population.5 Advance care plans support care congruent to patients stated 
preferences.6 However, limited information is available on established PC protocols and metrics 
in the MCS population. Prior to our protocol intervention, very few patients receiving MCS at 
our institution had an ACP and rarely was the PC team involved in their care. 
 We developed and implemented a collaborative protocol between the PC team and the 
VAD team to ensure a multidisciplinary approach and timely PC consultation for all patients 
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being considered for MCS implantation. Our protocol included all patients being evaluated for 
MCS regardless of whether they were DT or bridge to transplant (BTT) and even included total 
artificial heart (TAH) patients. Because of the complex needs of this patient population, we 
incorporated an interdisciplinary team approach to our PC consultation. We sought to assess 
whether our collaborative approach resulted in a significant increase in the completion of an 
interdisciplinary PC consult and documentation of a surrogate decision maker (SDM).  
MEASURES/ INTERVENTIONS 
Intervention 
 On March 1, 2014, a standardized PC consultation protocol for all MCS candidates was 
implemented at our institution (Figure 1). Our goal was to complete an interdisciplinary PC 
consultation on all patients prior to MCS implantation. This protocol relied on close 
collaboration between heart failure specialists, cardiothoracic surgeons, and PC specialists to 
enable timely and effective PC evaluations. This was elemental to the success of our intervention 
and required active engagement in the planning stage from both teams. The clinical nurse 
coordinators from both the PC and cardiology teams were designated as main contact persons to 
ensure consistent, shared communication. We developed a routine quarterly meeting between the 
teams to provide ongoing feedback and review of the protocol. We also participated in the 
weekly interdisciplinary team discussions for patients either with implanted MCS or undergoing 
evaluation for the same. 
Identification of Patients 
The Cardiology team identifies patients being evaluated for MCS implantation and then 
generates an electronic medical record alert for PC consult prior to implant. The protocol 
includes both DT and BTT designated patients as well as TAH patients. Including both DT and 
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BTT patients is advantageous, as BTT patients can experience future complications that would 
remove them from transplant consideration.7  
Content of the PC Consultation 
After the cardiology team enters an electronic medical record alert for PC consultation, 
there is direct communication between nurse coordinators on both teams to share pertinent 
information prior to evaluation. PC consultations incorporate visits from the interdisciplinary 
team which includes PC trained physicians or advanced practice nurses, PC social worker, and 
PC chaplain.  
Goals of the PC consultation are to facilitate identification and documentation of a SDM, 
to assist with ACP needs, and to provide symptom-based physical, emotional, psychosocial, and 
spiritual support to the patient and/or their family members. For this report, ACP is defined as 
discussing medical care that a patient would like to receive in the future in the event the patient is 
unable to speak for him or herself. ACP discussions are documented in a formatted PC clinical 
note, and advanced directives, including the SDM document, are scanned and saved in a fixed 
section for advanced directive in the electronic medical record for easy access. The existing PC 
inpatient consulting team is primarily used as our resource, and therefore, patients are seen when 
admitted to the hospital often when undergoing preparation for implantation. The PC team is not 
always part of the early decision-making process as patients are often admitted with the intent to 
implant an MCS. 
Our model includes an interdisciplinary and ongoing assessment by the PC clinician as 
well as the PC social worker and chaplain to address psychosocial and spiritual needs both 
before and after implantation. Visits are tailored according to the identified needs of the patient 
and family. In several cases, we have identified psychosocial and spiritual needs to be greater 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
PALLIATIVE CARE CONSULT PROTOCOL IN MCS CANDIDATES 
 
6 
 
than the medical needs. Examples of psychosocial needs include adjustment to illness, grief over 
loss of independence, and caregiver support. 
  Our PC consultation is not just limited to a preoperative consultation. After the initial 
evaluation, the PC team continues to work collaboratively with the cardiac team throughout 
MCS workup and after MCS implantation with regular patient visits. The protocol relies on PC 
involvement both before and after device implantation to ensure continuity of care and is not 
limited to ACP alone.  
Measures 
  A retrospective pre/post analysis was done to assess this protocol and its quality 
improvement impact. Chart review was performed on all patients who received MCS devices at 
our academic health center. The analysis included two observation periods: before the 
implementation of the standardized PC consultation protocol (pre-PC protocol) from January 1, 
2012, to February 28, 2014, and after implementation (post-PC protocol) from March 1, 2014, to 
December 31, 2015. Approval was obtained from the Indiana University Institutional Review 
Board for future study implications.   
 Patient demographic characteristics were obtained from the retrospective chart review. 
Detailed information about involvement of the PC team was also recorded, including: presence 
of PC consult pre and post implantation, presence of documented SDM pre and post-MCS 
implantation, members of the PC team involved in the patient’s care pre and post-MCS 
implantation, physical location of death for deceased patients, and PC team or hospice 
involvement at the time of death. 
Statistical Analysis  
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 For both demographic and participant outcomes, Student’s t-tests were performed for 
continuous variables to look for differences between groups (pre- vs. post-PCC protocol).  All 
analytic assumptions were verified, and Wilcoxon non-parametric tests were performed when 
continuous variables were determined to be non-linear.   For categorical variables, Fisher’s Exact 
tests were used to determine if there was significant heterogeneity between groups, due to low 
cell counts.  All analyses were performed using SAS v9.4 (SAS Institute, Cary, NC). 
OUTCOMES 
Demographics 
 There were 122 patients implanted with MCS devices from January 1, 2012, to December 
31, 2015, with 64 pre-protocol and 58 post–protocol patients (Table 1). The group prior to 
protocol implementation included more women (39.1% v. 20.7%, p=0.0315) and small 
differences in marital status (p=0.0497). The two groups were similar in other demographics. 
Mean age was 57.73±12.85 years and 54.86±12.85 years for pre- and post-protocol groups, 
respectively.  Hospital lengths of stay were skewed, and so are given with median (range), and 
are 30.6 days (13.2-148.9) and 30.1 days (0.4-95.0), respectively. 
Protocol Results 
 The total overall percentage of PC consults placed prior to MCS implantation was 54.9% 
(67) from 2012 to 2015. The percentage of PC consults placed prior to MCS implantation 
increased from 17.2 % (11) pre-protocol to 96.6% (56) post-protocol (p<0.0001), and 
documented SDM increased 40.6% (26) pre-protocol to 98.3% (57) post-protocol (p<0.0001; 
Table 1). Of note, the proportion of documents completed by the PC team (versus previously 
completed) did not change (80.8% v/ 79.0%. p=0.8487) as shown in Table 1.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
PALLIATIVE CARE CONSULT PROTOCOL IN MCS CANDIDATES 
 
8 
 
The use of the multidisciplinary PC team members in the MCS population before and 
after implant increased across all disciplines post-protocol (p<0.0001).  However, the distribution 
of team member use before and after implant was found not to be statistically different (p<0.10), 
suggesting that team members continued their involvement post implant (Table 1).   
 In the total patient sample (n=122), 31 patients (25.4%) were deceased as of data 
collection.  There were no statistical differences in the use of hospital-based palliative care 
(p=0.2930) or hospice care (p=0.2955) at the end of life between the pre-protocol (n=19; 29.7%) 
and post-protocol (n=12; 20.7%) samples.  The majority of patients both pre- protocol (84.2%) 
and post- protocol (83.3%) died in the hospital.  Only two patients both pre- and post- protocol 
died at home (p=0.6547).    
CONCLUSIONS 
 We developed a collaborative protocol between the PC and cardiology teams to include 
all patients undergoing evaluation for MCS. This was associated with near 100% rate of PC 
evaluations completed prior to MCS implantation and a substantial increase in the number of 
patients with a documented SDM. The Joint Commission has recommended the involvement of  
PC evaluation for DT VAD implants.4 However, our protocol was designed to include all MCS 
patients given the knowledge that BTT patients have similar needs for ACP and may get 
removed from the transplant list based on complications or clinical changes.7 
We used our electronic medical record system effectively to generate an automated PC 
consult trigger when a patient was identified. This guaranteed notification of the PC consultation 
request for the MCS population. The electronic medical record was also used for documentation 
and storage of ACP/SDM documents in a defined location to ensure easy and consistent 
accessibility. We had a standardized structure for documenting the ACP that was influenced by 
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the preparedness plan as suggested by Swetz et al.5 The basic requisite was to document patient 
preferences for ACP, name and contact information for SDM, and any symptoms needing to be 
addressed.  SDM documentation was used as a metric for our protocol success, because the goal 
of ACP is to include patients in shared decision-making and provide care in accordance with 
their preferences. Identifying a SDM is an important step to safeguard that patient wishes for 
care are honored.8,9  
While undergoing MCS implantation, patients are under anesthesia for a significant time 
period and on mechanical ventilation post-operatively. During this time period, patients are 
unable to speak for themselves. Patients may suffer minor or major complications leaving them 
incapacitated and unable to have complex medical discussions. Surrogacy laws vary by state, and 
in Indiana, the laws are particularly complex, with multiple family members having equal 
authority in decision making. Patients are often unaware of these laws. Even with a well-
developed ACP, surrogates are needed to interpret patient preferences and translate them into 
concrete medical decisions. By identifying a legal SDM and including the SDM in the ACP 
discussions, the goal is to ensure the patient’s wishes are honored in such an event. 
The development of this protocol identified a growing need for outpatient follow-up to 
provide symptom management and ongoing palliative support. Based on these observations an 
outpatient component to the collaboration has been established.  
 While the Joint Commission recommends a PC representative who has experience with 
the VAD patient population be part of the interdisciplinary team, we provided a 
multidimensional approach of care to the patients across the spectrum including needs beyond 
ACP. We were additionally able to provide this service to all patients under evaluation for MCS. 
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Challenges were identified in the implementation of the protocol. One challenge was how 
to allocate resources from an already busy service towards this specialized group of patients. We 
limited this challenge by tailoring visits based on needs after the first evaluation and by frequent 
chart reviews and close collaboration with the primary cardiology team and other staff.  Also, by 
utilizing our multidisciplinary approach effectively, we were able to limit the impact of this 
challenge on our PC service. Limited time constraints within a hospital stay during MCS workup 
added to the overwhelming amount of new staff members introduced to the patient and their 
family was also a challenge. An addition of an outpatient clinic for earlier counseling and 
decision making was identified as beneficial. Future studies could replicate the protocol at 
multiple centers using similar metrics for success. Another area to explore is how PC can benefit 
patients through psychosocial and symptom support during the course of MCS implantation. A 
similar model can be looked at in patients with serious illness who are considering discrete 
interventions such as renal replacement therapy, organ transplant, and any major preoperative 
evaluations.  Future research could also ascertain protocol impact on a patient’s end of life 
experience and care including the use of PC and hospice services. 
Limitations 
  The observations presented are from a relatively small cohort limited to one institution, 
and as such would need to be validated by implementation in different settings. Additionally, the 
data was retrospective and based on chart review, and ongoing evaluation of this protocol would 
be beneficial. The mortality numbers in the given cohort were not large enough to allow 
adequate assessment of benefits the PC team provided in end of life care. Also, the cohort is too 
small to allow comparisons between BTT and DT patients.  
Conclusions 
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 The results demonstrated that at a single institution, an automated PC consult protocol 
and interdisciplinary consult approach for MCS candidates results in completion of a PC consult 
and successful documentation of a SDM with a high success rate. Close collaboration and a 
multidisciplinary approach were found to be critical and fundamental to the success of this 
protocol. An integral element of the protocol was the communication between the team clinical 
nurse coordinators. An automated consultation trigger via the electronic medical record along 
with documentation within the electronic medical record proved beneficial. The desired outcome 
from the multidisciplinary approach was to provide care concordant with stated goals, reduced 
symptom burden, and to improve SDM education and documentation. 
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Table 1 
Patient Demographics and Results  
                                                                                           Pre-PC Protocol (n=64)                   Post-PC Protocol (n=58)                                  Total (n = 122)                    P-values1 
Patient Characteristics & Results                                      n (%)                                n (%)      n (%) 
Age (Range, Mean)                     24-75, 57.73                    26-78, 54.86                          24-78, 56.37 0.2200  
Hospital Length of Stay (Range, Mean)                     13.2-148.9, 34.6                                     0.4-95, 34.2                                                     0.4-148.9, 34.43 0.9837  
Sex                0.0315 
 Male    39 (60.9)   46 (79.3)   85 (69.7) 
 Female    25 (39.1)   12 (20.7)   37  (30.3) 
Race                0.6771 
 Caucasian    49 (76.6)   46 (79.3)   95  (77.9) 
 African American   14 (21.9)   9 (15.5)   23 (18.9) 
 Native Hawaiian or Pacific Islander 0 (0)   1 (1.7)   1    (0.8) 
 Hispanic    0 (0)   1 (1.7)   1    (0.8) 
 Unknown                     1                (1.6)        1 (1.7)   2    (1.6) 
Education                 0.8551 
 Some High School   5 (7.9)   7 (12.5)   12  (9.8) 
 High School/GED   32 (50.8)   26 (46.4)   8  (6.6) 
 <4 years College   18 (28.6)   17 (30.4)   19 (15.6)  
 College/Graduate Degree  8 (12.7)   6 (10.7)   11 (9.0) 
Marital Status               0.0497 
 Single    2 (3.1)   10 (17.2)   12 (9.8) 
 Significant Other   4 (6.3)   5 (8.6)   9 (7.4) 
 Married    45 (70.3)   35 (60.3)   80 (65.6) 
 Separated    2 (3.1)   2 (3.4)   4 (3.3) 
 Divorced    7 (10.9)   6 (10.3)   13 (10.7) 
 Widowed    4 (6.3)   0 (0)   4 (3.3) 
Type of Therapy                0.8543 
 BTT    25 (39.1)   24 (41.4)   49 (40.2) 
 DT    39 (60.9)   34 (58.6)   73 (59.8) 
MCS Implanted                0.0091 
 Heartware                                                     12 (18.8)   23 (39.7)   35 (28.7) 
 HeartMateII   51 (79.7)   32 (55.2)   83 (68.0) 
 HeartMateIII   0 (0)   2 (3.4)   2 (1.6) 
 TAH    1 (1.6)   1 (1.7)   2 (1.6) 
PC Consult Prior to Implant   11 (17.2)   56 (96.6)   67 (54.9)              <0.0001  
SDM Documented Prior to Implant  26 (40.6)   57 (98.3)   83 (68.0)              <0.0001    
                              
SDM Documents                                                                     0.8487 
Completed with PC Team  21 (80.8)   45 (79.0)   66  (79.5) 
 Pre-existing Documents  5 (19.2)   12 (21.1)   17  (20.5)  
PC Team Member Involvement2             <0.10 
Before MCS Implant              
 Physicians    10 (15.6)   41 (70.7)   51 (41.8)  <0.0001 
 Advanced Practice Nurses  6 (9.4)   27 (46.6)   33 (27.0)  <0.0001 
 Social Work   9 (14.1)   44 (75.9)   53 (43.4)  <0.0001 
 Chaplain    7 (10.9)   35 (60.3)   42 (34.4)  <0.0001 
After MCS Implant              
 Physicians    5 (7.8)   33 (56.9)   38 (31.1)  <0.0001 
 Advance Practice Nurses  5 (7.8)   26 (44.8)   31 (25.4)  <0.0001 
 Social Work                                                   9 (14.1)   50 (86.2)   59 (48.4)  <0.0001 
 Chaplain    7 (10.9)   35 (60.3)   42 (34.4)  <0.0001 
 
1P-values are from Fisher’s Exact tests for categorical variables, Student’s t-test for age, Wilcoxon non-parametric test for LOS 
2P-value from non-parametric two-sample Kolmogorov-Smirnov test 
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Figure 1 Palliative Care and Cardiology Protocol Diagram 
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